|
Neurogastrx Study on Gastroparesis
|
|
COMING SOON. A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of Investigational Product Administered Orally to Patients with Gastroparesis. This Clinical Trial will assess an oral D₂ antagonist for the treatment of idiopathic or diabetic gastroparesis.
|
|
|
|
|
|
|
|
|
|